Cardiome Pharma Corporation Operating Income 2016-2019 | CORV
Cardiome Pharma Corporation operating income from 2016 to 2019. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Cardiome Pharma Corporation Annual Operating Income (Millions of US $) |
|
|---|---|
| 2019 | $-27 |
| 2018 | $-26 |
| 2017 | $-23 |
| 2016 | $-15 |
| 2015 | $-22 |
| 2014 | $-17 |
| 2013 | $ |
| 2011 | $ |
| 2009 | $ |
| Cardiome Pharma Corporation Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2019-09-30 | $-8 |
| 2019-06-30 | $-9 |
| 2019-03-31 | $-7 |
| 2018-12-31 | $-4 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-10 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-6 |
| 2017-09-30 | $-5 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-5 |
| 2016-12-31 | $-5 |
| 2016-09-30 | $-4 |
| 2016-06-30 | $-5 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $-7 |
| 2015-09-30 | $-5 |
| 2015-06-30 | $-7 |
| 2015-03-31 | $-3 |
